StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5127
This month
17
This week
2
This year
154
Yesterday
2
Publishing Date
2022 - 12 - 08
21
2022 - 06 - 06
20
2022 - 05 - 23
16
2022 - 03 - 14
15
2022 - 03 - 08
15
2022 - 03 - 01
17
2022 - 02 - 28
15
2022 - 01 - 18
19
2022 - 01 - 04
16
2021 - 12 - 16
16
2021 - 12 - 14
17
2021 - 12 - 13
29
2021 - 12 - 09
23
2021 - 12 - 06
25
2021 - 11 - 30
17
2021 - 11 - 16
19
2021 - 11 - 15
18
2021 - 11 - 09
17
2021 - 11 - 08
19
2021 - 11 - 03
21
2021 - 10 - 28
17
2021 - 10 - 27
16
2021 - 10 - 25
19
2021 - 10 - 20
16
2021 - 10 - 18
17
2021 - 10 - 14
19
2021 - 10 - 13
20
2021 - 10 - 07
21
2021 - 09 - 30
15
2021 - 09 - 28
15
2021 - 09 - 13
27
2021 - 09 - 09
17
2021 - 09 - 08
21
2021 - 08 - 31
15
2021 - 08 - 05
15
2021 - 07 - 27
18
2021 - 07 - 15
16
2021 - 07 - 07
15
2021 - 07 - 06
16
2021 - 07 - 01
15
2021 - 06 - 29
18
2021 - 06 - 28
24
2021 - 06 - 24
18
2021 - 06 - 23
25
2021 - 06 - 16
16
2021 - 06 - 08
15
2021 - 06 - 07
22
2021 - 05 - 20
16
2021 - 05 - 12
16
2021 - 04 - 29
15
2021 - 04 - 15
15
2021 - 04 - 12
17
2021 - 03 - 18
19
2021 - 03 - 15
16
2021 - 03 - 10
15
2021 - 03 - 09
15
2021 - 02 - 10
15
2021 - 01 - 11
15
2020 - 12 - 10
17
2020 - 12 - 01
15
Sector
Accommodation and food services
1
Administrative and support and waste management and remediation services
4
Arts, entertainment, and recreation
5
Commercial services
74
Communications
54
Consumer durables
38
Consumer non-durables
23
Consumer services
19
Distribution services
37
Electronic technology
140
Energy minerals
17
Finance
188
Finance and insurance
20
Health care and social assistance
11
Health services
57
Health technology
3117
Industrial services
39
Information
19
Manufacturing
360
Mining, quarrying, and oil and gas extraction
12
Miscellaneous
9
N/a
86
Non-energy minerals
28
Process industries
131
Producer manufacturing
442
Professional, scientific, and technical services
126
Real estate and rental and leasing
8
Retail trade
52
Technology services
136
Transportation
37
Transportation and warehousing
14
Utilities
6
Wholesale trade
1
Tags
Acquisition
4244
Application
1781
Approval
1706
Awards
1448
Cancer
2823
Ceo
1673
Ces
4255
Collaboration
1769
Conference
14983
Contract
1510
Corporation
2443
Covid
2680
Covid-19
1834
Deadline
2004
Disease
1876
Distribution
2193
Drug
1968
Earnings
2846
Energy
4959
Europe
1748
Ev
1455
Events
3801
Fda
2323
Financial
2690
Financial results
8251
For
13399
Global
3929
Group
2282
Growth
7981
Health
3351
Iot
1741
Liver
1420
Market
11412
Media
1478
N/a
175064
Nasdaq
1892
Offering
5394
Partnership
1815
People
2010
Pharm-country
1493
Pharma
1536
Phase 2
1404
Platform
1415
Positive
2067
Presentation
2330
Program
2337
Report
8352
Research
7223
Results
26522
Sales
1567
Services
1445
System
1713
Technology
4147
Test
2086
Therapeutics
4901
Therapy
2201
Treatment
3622
Trial
5127
Update
1528
Vaccine
1617
Entities
Abb ltd
72
Abbvie inc.
19
Aldeyra therapeutics, inc.
19
Alterity therapeutics limited
14
Altra industrial motion corp.
23
Anavex life sciences corp.
15
Arcutis biotherapeutics, inc.
16
Arrival
19
Ascendis pharma a/s
16
Astellas pharma inc
14
Astrazeneca plc
28
Axsome therapeutics, inc.
15
Beigene, ltd.
21
Biohaven pharmaceutical holding company ltd.
17
Bristol-myers squibb company
32
Cnh industrial n.v.
69
Csw industrials, inc.
19
Cytokinetics, incorporated
17
Dynavax technologies corporation
22
Eli lilly and company
87
Enlivex therapeutics ltd.
15
Exelixis, inc.
22
First industrial realty trust, inc.
15
Gates industrial corporation plc
25
General electric company
16
Gilead sciences, inc.
16
Global industrial co
37
Honeywell international inc.
53
Horizon therapeutics public limited company
24
Hoth therapeutics, inc.
14
Hutchison china meditech limited
19
I-mab
19
Icon plc
19
Immunitybio inc
15
Incyte corporation
17
Johnson & johnson
74
Johnson controls international plc
22
Medtronic plc
19
Merck & company, inc.
28
Moleculin biotech, inc.
19
Morgan stanley
15
Msc industrial direct company, inc.
16
Novartis ag
14
Novavax, inc.
20
Novo nordisk a/s
25
Novocure limited
15
Ocuphire pharma inc.
17
Orange
45
Otonomy, inc.
16
Pds biotechnology corporation
15
Pfizer, inc.
34
Plus therapeutics, inc.
18
Regeneron pharmaceuticals, inc.
21
Regenxbio inc.
16
Rockwell automation, inc.
19
Sanofi
109
Sorrento therapeutics, inc.
28
Stag industrial, inc.
32
Takeda pharmaceutical company limited
29
Thermo fisher scientific inc
17
Symbols
ABB
72
ABBV
19
ABLZF
31
AIMC
23
ALDX
19
ALPMF
14
ALPMY
14
ARQT
16
ARVL
19
ASND
16
AVXL
15
AXSM
15
AZN
28
BGNE
21
BHVN
17
BMY
32
CNHI
69
CSWI
19
CYTK
17
DVAX
22
ENLV
15
EXEL
22
FNCTF
45
FR
15
GE
16
GIC
37
GILD
16
GTES
25
HCM
19
HON
53
HZNP
24
IBRX
15
ICLR
19
IMAB
19
INCY
17
JCI
22
JNJ
74
LLY
87
MBRX
19
MDT
19
MRK
28
MS
15
MSM
16
NVAX
20
NVCR
15
NVO
25
OCUP
17
OTIC
16
PDSB
15
PFE
34
PSTV
18
REGN
21
RGNX
16
ROK
19
SNY
109
SNYNF
64
SRNE
28
STAG
32
TAK
29
TMO
17
Exchanges
Amex
67
Lse
45
Nasdaq
4011
Nyse
1343
Tsx
31
Crawled Date
2022 - 12 - 08
23
2022 - 06 - 06
21
2022 - 05 - 23
16
2022 - 03 - 01
17
2022 - 02 - 28
15
2022 - 02 - 15
15
2022 - 01 - 18
18
2022 - 01 - 04
16
2021 - 12 - 16
16
2021 - 12 - 14
16
2021 - 12 - 13
28
2021 - 12 - 09
21
2021 - 12 - 06
25
2021 - 11 - 30
17
2021 - 11 - 16
20
2021 - 11 - 15
17
2021 - 11 - 09
16
2021 - 11 - 08
21
2021 - 11 - 03
20
2021 - 10 - 28
17
2021 - 10 - 27
16
2021 - 10 - 26
15
2021 - 10 - 25
18
2021 - 10 - 20
16
2021 - 10 - 19
15
2021 - 10 - 18
15
2021 - 10 - 14
20
2021 - 10 - 13
19
2021 - 10 - 12
15
2021 - 10 - 07
21
2021 - 09 - 30
15
2021 - 09 - 28
16
2021 - 09 - 13
28
2021 - 09 - 09
17
2021 - 09 - 08
21
2021 - 08 - 31
15
2021 - 08 - 05
15
2021 - 07 - 27
17
2021 - 07 - 15
16
2021 - 07 - 07
15
2021 - 07 - 06
17
2021 - 06 - 29
19
2021 - 06 - 28
22
2021 - 06 - 25
15
2021 - 06 - 24
17
2021 - 06 - 23
26
2021 - 06 - 16
16
2021 - 06 - 08
15
2021 - 06 - 07
22
2021 - 05 - 20
16
2021 - 05 - 12
16
2021 - 04 - 15
17
2021 - 04 - 12
16
2021 - 03 - 18
20
2021 - 03 - 15
16
2021 - 01 - 11
15
2020 - 12 - 10
17
2020 - 12 - 09
19
2020 - 12 - 03
25
2020 - 12 - 01
27
Crawled Time
00:00
110
00:12
4
00:20
31
01:00
80
02:00
28
03:00
22
03:10
4
04:00
19
04:20
18
05:00
23
06:00
48
07:00
72
08:00
38
08:20
5
09:00
51
09:33
4
10:00
56
10:08
8
11:00
214
11:03
4
12:00
570
12:01
16
12:03
25
12:15
125
12:20
117
12:30
75
13:00
495
13:01
18
13:03
15
13:05
7
13:07
5
13:15
100
13:20
107
13:30
102
13:35
6
14:00
437
14:01
10
14:03
6
14:15
49
14:20
54
14:30
53
15:00
259
15:15
34
15:20
23
15:30
43
16:00
145
16:01
5
16:20
38
17:00
162
18:00
121
19:00
119
20:00
121
20:20
28
21:00
192
22:00
213
22:01
8
22:08
6
22:10
5
22:16
8
23:00
132
Source
aimimmuno.com
1
alteritytherapeutics.com
9
alzamend.com
3
contravir.com
5
investor.assemblybio.com
2
ir.anaptysbio.com
2
ir.arberobotics.com
2
ir.benitec.com
2
ir.hoththerapeutics.com
5
ir.kalvista.com
3
ir.opgen.com
2
ir.radiuspharm.com
3
ir.vaccinex.com
2
ir.viveve.com
6
ir.zynerba.com
2
mindmed.co
2
ocutx.gcs-web.com
2
spacfeed.com
4
velodynelidar.com
9
www.4dpharmaplc.com
6
www.achievelifesciences.com
5
www.adnas.com
5
www.agtc.com
5
www.akerotx.com
3
www.allogene.com
2
www.anaptysbio.com
2
www.anavex.com
4
www.aquestive.com
3
www.athira.com
3
www.atyrpharma.com
3
www.balchem.com
2
www.biospace.com
2254
www.brainsway.com
3
www.celyad.com
3
www.chi-med.com
2
www.cortexyme.com
3
www.daxor.com
2
www.fatetherapeutics.com
6
www.fda.gov
7
www.fsdpharma.com
3
www.globenewswire.com
1337
www.igcinc.us
6
www.immatics.com
2
www.inovio.com
7
www.inventivapharma.com
5
www.janone.com
2
www.jupiterwellnessinc.com
6
www.marronebio.com
2
www.nantkwest.com
9
www.novocure.com
5
www.nurixtx.com
2
www.obseva.com
2
www.oramed.com
2
www.prnewswire.com
1247
www.rubiustx.com
2
www.spigroups.com
2
www.stagindustrial.com
21
www.veeva.com
3
www.vynetherapeutics.com
3
www.zynerba.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Trial
save search
AFRM IMPORTANT DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Affirm Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - AFRM
Published:
2023-02-04
(Crawled : 00:20)
- prnewswire.com
FXLV
|
News
|
$3.16
1.61%
0.0%
480K
|
Arts, Entertainment, and Recrea...
|
Email alert
Add to watchlist
AFRM
|
News
M
|
$18.14
-14.19%
-16.54%
29M
|
|
Email alert
Add to watchlist
trial
deadline
FXLV IMPORTANT DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages F45 Training Holdings Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - FXLV
Published:
2023-02-04
(Crawled : 20:20)
- prnewswire.com
FXLV
|
News
|
$3.16
1.61%
0.0%
480K
|
Arts, Entertainment, and Recrea...
|
Email alert
Add to watchlist
BLRX
|
News
|
$0.62
1.39%
1.37%
320K
|
Health Technology
|
Email alert
Add to watchlist
trial
deadline
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
Published:
2023-02-03
(Crawled : 16:00)
- biospace.com/
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-4.01%
|
O:
-4.01%
H:
0.0%
C:
0.0%
for
trial
sanofi
Blueprint Medicines to Present Positive Data from PIONEER Trial of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting
Published:
2023-02-03
(Crawled : 14:20)
- prnewswire.com
BPMC
|
$45.64
-6.97%
-7.49%
810K
|
Health Technology
|
5.37%
|
O:
5.37%
H:
0.0%
C:
0.0%
ayvakit
meeting
trial
positive
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
Published:
2023-02-02
(Crawled : 22:00)
- globenewswire.com
UTHR
M
|
$252.81
-2.57%
-2.64%
500K
|
Health Technology
|
0.59%
|
O:
0.59%
H:
0.0%
C:
0.0%
patent
trial
therapeutics
Skye Bioscience Retains Lexitas Pharma Services as CRO for Phase 2 Trial of SBI-100 Ophthalmic Emulsion
Published:
2023-02-02
(Crawled : 16:00)
- biospace.com/
SKYE
|
$0.0503
0
|
Transportation and Warehousing
|
Email alert
Add to watchlist
sbi-100
pharma
services
for
trial
bioscience
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossExpects to Commence Phase 2a of CAReS During the First Quarter of 2023
Published:
2023-02-02
(Crawled : 15:20)
- biospace.com/
AZN
|
$63.45
0.48%
0.47%
4.8M
|
Health Technology
|
0.14%
|
O:
-0.33%
H:
0.0%
C:
0.0%
ARTL
A
|
$3.06
-0.65%
-0.65%
36K
|
Health Technology
|
-1.27%
|
O:
-1.27%
H:
0.0%
C:
0.0%
art27
treatment
cares
for
trial
art27.13
Amylyx Pharmaceuticals Announces Completion of Enrollment in Global Phase 3 PHOENIX Trial of AMX0035 in ALS
Published:
2023-02-02
(Crawled : 15:00)
- biospace.com/
AMLX
|
$36.6
-1.08%
-1.09%
650K
|
|
-6.07%
|
O:
-0.2%
H:
3.98%
C:
-5.88%
amx0035
pharmaceuticals
global
als
trial
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published:
2023-02-02
(Crawled : 14:20)
- globenewswire.com
AZN
|
$63.45
0.48%
0.47%
4.8M
|
Health Technology
|
0.14%
|
O:
-0.33%
H:
0.0%
C:
0.0%
ARTL
A
|
$3.06
-0.65%
-0.65%
36K
|
Health Technology
|
-1.27%
|
O:
-1.27%
H:
0.0%
C:
0.0%
art27
treatment
cares
for
trial
art27.13
Anavex Life Sciences Announces Exceeding of Enrollment Target for the ANAVEX®2-73 (blarcamesine) EXCELLENCE Phase 2/3 Rett Syndrome Clinical Trial
Published:
2023-02-02
(Crawled : 14:00)
- biospace.com/
AVXL
|
$11.27
-0.88%
-0.89%
1.1M
|
Health Technology
|
2.76%
|
O:
2.76%
H:
0.0%
C:
0.0%
anavex
anavex®2-73
trial
rett syndrome
MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody® sonelokimab in moderate-to-severe hidradenitis suppurativa
Published:
2023-02-02
(Crawled : 13:20)
- globenewswire.com
MLTX
|
$12.08
0.25%
0.25%
85K
|
|
0.84%
|
O:
2.51%
H:
1.71%
C:
-1.63%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-5.4%
|
O:
-1.44%
H:
0.0%
C:
0.0%
nanobody
trial
First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic FibrosisPatient dosing expected to begin in mid-February with topline data anticipated by mid-2023
Published:
2023-02-02
(Crawled : 13:00)
- biospace.com/
FWBI
|
$5.14
-5.34%
-5.64%
270K
|
Manufacturing
|
2.45%
|
O:
-3.21%
H:
25.54%
C:
5.85%
biopharma
for
topline
expected
trial
NRx Pharmaceuticals Reports Recommendations of Data Safety Monitoring Board for Trial of NRX-101 in Patients with Severe Bipolar Depression and Subacute Suicidal Ideation or Behavior
Published:
2023-02-02
(Crawled : 12:00)
- prnewswire.com
NRXP
|
$1.255
0.4%
0.4%
130K
|
Manufacturing
|
5.93%
|
O:
-0.85%
H:
6.84%
C:
6.84%
nrx-101
pharmaceuticals
for
trial
depression
NBEV DEADLINE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages NewAge Inc. Investors to Secure Counsel Before Important February 6 Deadline in Securities Class Action Initiated by the Firm - NBEV, NBEVQ
Published:
2023-02-02
(Crawled : 01:00)
- prnewswire.com
TTCF
|
$1.65
-4.07%
-4.24%
1.4M
|
Consumer Non-Durables
|
12.42%
|
O:
9.15%
H:
10.18%
C:
2.99%
SPPI
S
|
$0.829
2.88%
2.8%
2M
|
Health Technology
|
13.49%
|
O:
28.17%
H:
1.1%
C:
-11.45%
trial
trusted
deadline
initiated
Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer
Published:
2023-02-01
(Crawled : 15:00)
- biospace.com/
MRSN
|
$7.025
1.96%
1.92%
1.3M
|
Health Technology
|
4.71%
|
O:
0.15%
H:
3.03%
C:
1.97%
expansion
trial
therapeutics
cancer
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published:
2023-02-01
(Crawled : 14:00)
- biospace.com/
GRNA
|
$1.135
1.34%
1.32%
220K
|
Professional, Scientific, and T...
|
6.16%
|
O:
9.76%
H:
0.0%
C:
-5.87%
covid-19
candidate
vaccine
mrna
trial
approval
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tattooed Chef, Inc. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm - TTCF
Published:
2023-02-01
(Crawled : 04:00)
- prnewswire.com
TTCF
|
$1.65
-4.07%
-4.24%
1.4M
|
Consumer Non-Durables
|
10.97%
|
O:
-1.29%
H:
0.0%
C:
0.0%
DAKT
|
$4.12
-0.48%
-0.49%
260K
|
Electronic Technology
|
3.91%
|
O:
1.47%
H:
2.77%
C:
0.96%
trial
deadline
AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial
Published:
2023-01-31
(Crawled : 17:00)
- biospace.com/
ATRC
|
$47.23
0.02%
0.02%
190K
|
Health Technology
|
Email alert
Add to watchlist
trial
Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis
Published:
2023-01-31
(Crawled : 14:00)
- biospace.com/
ARCT
|
$21.97
-4.1%
-4.28%
370K
|
Health Technology
|
7.93%
|
O:
-0.64%
H:
4.14%
C:
4.14%
arct-032
fibrosis
for
application
trial
approval
therapeutics
First Wave BioPharma Announces Initiation of Phase 2 Trial Investigating Enhanced Adrulipase Formulation in Exocrine Pancreatic Insufficiency in Patients with Cystic Fibrosis
Published:
2023-01-31
(Crawled : 13:00)
- biospace.com/
FWBI
|
$5.14
-5.34%
-5.64%
270K
|
Manufacturing
|
-2.69%
|
O:
-0.9%
H:
4.88%
C:
-1.99%
biopharma
fibrosis
trial
pancreatic
← Previous
1
2
3
4
5
6
7
8
9
…
256
257
Next →
Gainers vs Losers
63%
37%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.